Scynexis Inc

SCYX chart

Scynexis Inc news

• SCYNEXIS, Inc. Estimates – NASDAQ:SCYX

  TradingView · Oct 23, 8:54 AM EDT

• SCYNEXIS, Inc. (SCYX) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Oct 23, 2:54 AM EDT

• SCYNEXIS (SCYX) Reports Positive Phase 1 Data for SCY-247 Antifu

  GuruFocus · Oct 22, 9:02 AM EDT

• SCYNEXIS reports phase 1 results for IV antifungal SCY-247

  Investing.com · Oct 22, 8:36 AM EDT

• SCYNEXIS Completes Phase 1 Study of Intravenous SCY-247, a Novel, Triterpenoid Antifungal in Development for Treatment and Prevention of Invasive Fungal Diseases

  Yahoo Finance · Oct 22, 8:00 AM EDT

• 56 healthy participants had no drug-related serious events with an experimental antifungal.

  Stock Titan · Oct 22, 8:00 AM EDT

• SCYNEXIS completes Phase 1 trial of SCY-247 ant...

  Pluang · Oct 22, 3:00 AM EDT

• SCYNEXIS to present antifungal drug SCY-247 at ...

  Pluang · Oct 21, 4:25 PM EDT

• SCYNEXIS to Feature SCY-247 in a Pipeline Presentation at IDWeek

  Yahoo Finance · Oct 21, 4:05 PM EDT

• SCYNEXIS will present a candidate that may act against drug-resistant fungi

  Stock Titan · Oct 21, 4:05 PM EDT

• SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  Yahoo Finance · Oct 6, 7:30 AM EDT

• Scynexis stock surges on $214M BARDA contract for SCY-247

  Yahoo Finance · Sep 28, 9:58 AM EDT

Scynexis Inc key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-09-28
• 8-K8-K2026-09-22
• 8-K8-K2026-09-10
• 10-Q10-Q2026-08-10
• 8-K8-K2026-06-26
• 8-K8-K2026-05-29
• 8-K8-K2026-05-22
• 10-Q10-Q2026-05-11
• DEF 14ADEF 14A2026-04-30
• DEF 14ADEF 14A2026-04-27
• 8-K8-K2026-04-20
• 8-K8-K2026-03-31

About Scynexis Inc

Ticker

SCYX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Jersey City, NJ

Fiscal year end

December 31

SEC CIK

1178253

Frequently asked questions